ArticleGeriatrics & gerontology international2026
Coexisting Anemia and Elevated C-Reactive Protein in Relation to Memory-Related Cognitive Outcomes: Evidence From CHARLS With Exploratory Support From ELSA.
Article in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimTo examine whether coexisting anemia and elevated C-reactive protein (CRP), reflecting a potential dual vascular-inflammatory burden, are associated with memory-related cognitive outcomes in middle-aged and older adults, using CHARLS as the primary cohort and ELSA for exploratory cross-cohort support.
methodsLongitudinal data from 5166 CHARLS participants were analyzed. Anemia was defined using sex-specific hemoglobin thresholds, and elevated CRP was defined as CRP > 3 mg/L. Participants were categorized into four anemia-CRP exposure groups. Multivariable linear regression models examined 2015 cognitive scores and cognitive change from 2011 to 2015. The primary outcomes were 2015 immediate recall, delayed recall, and memory scores. Other cognitive measures and cognitive change were secondary outcomes, whereas low cognitive performance and the CHARLS-ELSA pooled analysis were exploratory. Robustness was assessed using multiple sensitivity analyses, including bootstrap resampling, mixed-effects models, inverse probability weighting, and false discovery rate correction.
resultsIn CHARLS, participants with both anemia and elevated CRP had poorer 2015 memory-related cognitive performance than those with neither condition. After false discovery rate correction, associations remained significant across the memory-related outcomes, including immediate recall, delayed recall, and memory. The strongest associations were observed for delayed recall (β = -0.541, 95% CI: -0.888 to -0.194; FDR-adjusted p = 0.024) and memory (β = -0.983, 95% CI: -1.579 to -0.387; FDR-adjusted p = 0.024). Associations with global cognition and cognitive change were directionally consistent but did not remain statistically significant after FDR correction.
conclusionsCoexisting anemia and elevated CRP were associated with poorer memory-related cognitive performance in middle-aged and older adults. Longitudinal cognitive changes require cautious interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.